Influenza vaccination during early pregnancy and risk of major birth defects, US Birth Defects Study To Evaluate Pregnancy exposureS, 2014–2019

IF 4.5 3区 医学 Q2 IMMUNOLOGY
Veronica Malange , Tasnim Mohaissen , Kristin M. Conway , Anthony Rhoads , Joan K. Morris , Elizabeth C. Ailes , Paula L. Hedley , Janet D. Cragan , Eirini Nestoridi , Eleni A. Papadopoulos , Thomas D. Scholz , Alpa Sidhu , Michael Christiansen , Paul A. Romitti , the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS)
{"title":"Influenza vaccination during early pregnancy and risk of major birth defects, US Birth Defects Study To Evaluate Pregnancy exposureS, 2014–2019","authors":"Veronica Malange ,&nbsp;Tasnim Mohaissen ,&nbsp;Kristin M. Conway ,&nbsp;Anthony Rhoads ,&nbsp;Joan K. Morris ,&nbsp;Elizabeth C. Ailes ,&nbsp;Paula L. Hedley ,&nbsp;Janet D. Cragan ,&nbsp;Eirini Nestoridi ,&nbsp;Eleni A. Papadopoulos ,&nbsp;Thomas D. Scholz ,&nbsp;Alpa Sidhu ,&nbsp;Michael Christiansen ,&nbsp;Paul A. Romitti ,&nbsp;the Birth Defects Study To Evaluate Pregnancy exposureS (BD-STEPS)","doi":"10.1016/j.vaccine.2025.127297","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Studies of influenza vaccination during pregnancy and major birth defects generally provide reassuring findings. To maintain public confidence, it is important to continue evaluating the safety of maternal vaccination using well characterized, population-based data. This study extended previous research to examine associations between maternal influenza vaccination and selected birth defects using data from the Birth Defects Study To Evaluate Pregnancy exposureS, a US, multisite case-control study.</div></div><div><h3>Methods</h3><div>Mothers of case children (diagnosed with a birth defect) and control children (without a birth defect diagnosis) were identified from population-based birth defect surveillance programs and recruited to complete a telephone interview. Data from 2675 case and 1575 control mothers (participants) with deliveries during 2014–2019 were analyzed. Influenza vaccination exposure during the critical exposure period (one month before pregnancy through the first pregnancy month [B1P1] for spina bifida or through the third pregnancy month [B1P3] for other selected birth defects) was assessed controlling for several participant covariates. Logistic regression with propensity score adjustment was used to estimate adjusted odds ratios (aORs) and 95 % confidence intervals (CIs). Several secondary analyses were conducted. A probabilistic bias analysis examined the effect of exposure misclassification.</div></div><div><h3>Results</h3><div>The aOR observed between B1P1 influenza vaccination exposure and spina bifida was 0.9 (95 % CI: 0.4–2.0). The aORs for B1P3 exposure and other selected birth defects examined ranged from 0.4 to 1.3, with 95 % CIs including the null except those for cleft lip ± cleft palate (aOR: 0.6; 95 % CI: 0.4–0.9) and gastroschisis (aOR: 0.4; 95 % CI: 0.2–0.7). Results from secondary analyses were similar to the primary analyses, and those from probabilistic bias analysis were similar to respective primary and secondary analyses.</div></div><div><h3>Conclusion</h3><div>Findings showed no statistically significant positive associations between influenza vaccination and the selected birth defects, supporting public health efforts to promote optimal vaccination coverage among pregnant women.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"59 ","pages":"Article 127297"},"PeriodicalIF":4.5000,"publicationDate":"2025-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25005948","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

Studies of influenza vaccination during pregnancy and major birth defects generally provide reassuring findings. To maintain public confidence, it is important to continue evaluating the safety of maternal vaccination using well characterized, population-based data. This study extended previous research to examine associations between maternal influenza vaccination and selected birth defects using data from the Birth Defects Study To Evaluate Pregnancy exposureS, a US, multisite case-control study.

Methods

Mothers of case children (diagnosed with a birth defect) and control children (without a birth defect diagnosis) were identified from population-based birth defect surveillance programs and recruited to complete a telephone interview. Data from 2675 case and 1575 control mothers (participants) with deliveries during 2014–2019 were analyzed. Influenza vaccination exposure during the critical exposure period (one month before pregnancy through the first pregnancy month [B1P1] for spina bifida or through the third pregnancy month [B1P3] for other selected birth defects) was assessed controlling for several participant covariates. Logistic regression with propensity score adjustment was used to estimate adjusted odds ratios (aORs) and 95 % confidence intervals (CIs). Several secondary analyses were conducted. A probabilistic bias analysis examined the effect of exposure misclassification.

Results

The aOR observed between B1P1 influenza vaccination exposure and spina bifida was 0.9 (95 % CI: 0.4–2.0). The aORs for B1P3 exposure and other selected birth defects examined ranged from 0.4 to 1.3, with 95 % CIs including the null except those for cleft lip ± cleft palate (aOR: 0.6; 95 % CI: 0.4–0.9) and gastroschisis (aOR: 0.4; 95 % CI: 0.2–0.7). Results from secondary analyses were similar to the primary analyses, and those from probabilistic bias analysis were similar to respective primary and secondary analyses.

Conclusion

Findings showed no statistically significant positive associations between influenza vaccination and the selected birth defects, supporting public health efforts to promote optimal vaccination coverage among pregnant women.
妊娠早期接种流感疫苗和重大出生缺陷的风险,美国出生缺陷研究评估妊娠暴露,2014-2019
目的对妊娠期流感疫苗接种和主要出生缺陷的研究通常提供了令人放心的结果。为了保持公众信心,重要的是继续使用特征明确的、基于人群的数据来评估孕产妇疫苗接种的安全性。这项研究扩展了先前的研究,利用美国多地点病例对照研究“出生缺陷研究评估妊娠暴露”的数据,检查母亲接种流感疫苗与选定的出生缺陷之间的关系。方法从以人口为基础的出生缺陷监测项目中确定病例儿童(诊断为出生缺陷)和对照儿童(未诊断为出生缺陷)的母亲,并招募他们完成电话访谈。分析了2014-2019年期间分娩的2675名病例母亲和1575名对照母亲(参与者)的数据。在关键暴露期(妊娠前一个月至脊柱裂的第一个妊娠月[B1P1]或其他选定的出生缺陷的第三个妊娠月[B1P3])接种流感疫苗进行评估,控制几个参与者的共变量。采用倾向评分调整的Logistic回归估计校正优势比(aORs)和95%置信区间(ci)。进行了几次二次分析。概率偏倚分析检验了暴露错误分类的影响。结果接种B1P1流感疫苗与脊柱裂的aOR为0.9 (95% CI: 0.4 ~ 2.0)。B1P3暴露和其他选择的出生缺陷的aOR在0.4到1.3之间,95%的ci包括零,除了唇裂±腭裂(aOR: 0.6;95% CI: 0.4 - 0.9)和腹裂(aOR: 0.4;95% ci: 0.2-0.7)。二次分析结果与主要分析结果相似,概率偏倚分析结果与主要分析和次要分析结果相似。结论流感疫苗接种与出生缺陷之间无统计学显著正相关,支持公共卫生部门在孕妇中推广最佳疫苗接种覆盖率的努力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Vaccine
Vaccine 医学-免疫学
CiteScore
8.70
自引率
5.50%
发文量
992
审稿时长
131 days
期刊介绍: Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信